Global Non-invasive Blood Glucose Detector Market Growth 2024-2030
A non-invasive blood glucose meter is a device that monitors blood sugar without puncturing the skin to obtain a blood sample. Such monitors typically use infrared light, spectroscopy, or other sensing technology to measure blood glucose levels without the need to prick the skin to obtain a blood sample. Non-invasive blood glucose monitoring can avoid the pain of POCT and CGM puncture wounds, reduce testing costs, and avoid safety issues such as blood infections and diseases. It can realize real-time monitoring of detection results and obtain dynamic changes in blood sugar trends. Judging from the products on the market, the current non-invasive blood glucose monitoring principles can be roughly divided into measuring blood substitutes and micro-osmosis methods, biosensor methods, spectroscopy methods, metabolic conservation methods, etc. The non-invasive blood glucose meter can be integrated into a device or system as a multi-parameter module, such as the non-invasive module part of a hybrid blood glucose meter, or it can be a wearable non-invasive blood glucose device/non-invasive blood glucose sensor, and also includes a flexible non-invasive blood glucose sensor. Although non-invasive blood glucose meters are conceptually very attractive, there are still relatively few reliable and accurate non-invasive blood glucose meters on the market today. The accuracy and reliability of these devices can be affected by a variety of factors, such as skin pigment, temperature, humidity, etc.
The global Non-invasive Blood Glucose Detector market size is projected to grow from US$ 4643 million in 2024 to US$ 18470 million in 2030; it is expected to grow at a CAGR of 25.9% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Non-invasive Blood Glucose Detector Industry Forecast” looks at past sales and reviews total world Non-invasive Blood Glucose Detector sales in 2023, providing a comprehensive analysis by region and market sector of projected Non-invasive Blood Glucose Detector sales for 2024 through 2030. With Non-invasive Blood Glucose Detector sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive Blood Glucose Detector industry.
This Insight Report provides a comprehensive analysis of the global Non-invasive Blood Glucose Detector landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-invasive Blood Glucose Detector portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-invasive Blood Glucose Detector market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive Blood Glucose Detector and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive Blood Glucose Detector.
Global key players of Non-invasive Blood Glucose Detector include Abbott, Dexcom, Ghalife, etc. The top three players hold a share over 65%. Europe is the largest market, and has a share about 36%, followed by Asia-Pacific and North America with share 34% and 25%, separately. In terms of product type, Wearable Devices is the largest segment, occupied for a share of 95%. In terms of application, At-home Use has a share about 94 percent.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive Blood Glucose Detector market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Wearable Devices
Non-wearable System
Segmentation by Application:
At-home Use
Hospitals and Clinics
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
Dexcom
Cnoga Medical
Ghalife
Glucowise (Meta Materials Inc.)
GlucoTrack
Know Labs
Light Touch Technology
DiaMonTech
Taiwan Biophotonic
Afon Technology
Hagar
RSP systems
PKVitality
LifePlus
Key Questions Addressed in this Report
What is the 10-year outlook for the global Non-invasive Blood Glucose Detector market?
What factors are driving Non-invasive Blood Glucose Detector market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-invasive Blood Glucose Detector market opportunities vary by end market size?
How does Non-invasive Blood Glucose Detector break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.